Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Canada. It is testing pregabalin (Lyrica) Augmentation for OCD.
In HamiltonThis study is completed in the United States. It focuses on Depression.
Multiple locations, including BaltimoreThis study is completed in the United States. It is testing psilocybin for depression.
Multiple locations, including San FranciscoThis study is active but not recruiting in the United States. It is testing psilocybin for PTSD.
In BaltimoreThis study is completed. It is testing QT and QTc Intervals for Schizophrenia.
Location not clearly listedThis study is completed. It is testing QT and QTc Intervals for Schizophrenia.
Location not clearly listedThis study was terminated in the United States. It is testing rapastinel for depression.
Multiple locations, including BirminghamThis study is completed in France, in the United Kingdom, in Austria, .... It is testing Long-acting Injectable Risperidone and Quetiapine Tablets for schizophrenia.
Multiple locations, including Hall in Tirol
This study is completed in China. It is testing repetitive Transcranial Magnetic Stimulation for Bipolarity.
In GuangzhouThis study is completed. It is testing risperidone for Schizophrenia.
Location not clearly listedThis study was terminated in Australia, in Canada, in the United Kingdom, .... It is testing Risperidone Long-Acting Injection Versus Oral Antipsychotics for schizophrenia.
Multiple locations, including DandenongThis study is completed in the United States. It is testing risperidone Monotherapy for anxiety.
Multiple locations, including TampaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.